Qi Feng

Guangdong Provincial Key Laboratory Of Spine And Spinal Cord Reconstruction
Heyuan, 517000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Selenized Tripterine Phytosomes Alleviate Ferroptosis-Mediated Acute Kidney Injury by Suppressing GPX4 Degradation via the DUSP1/Autophagy Pathway.

Selenized Tripterine Phytosomes Alleviate Ferroptosis-Mediated Acute Kidney Injury by Suppressing GPX4 Degradation via the DUSP1/Autophagy Pathway.

Journal: Biomaterials research

Published: April 08, 2025

Malate, a natural inhibitor of 6PGD, improves the efficacy of chemotherapy in lung cancer.

Malate, a natural inhibitor of 6PGD, improves the efficacy of chemotherapy in lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 02, 2023

Effectiveness and safety profile of introducing less invasive surfactant administration in management of respiratory distress syndrome: A retrospective cohort study in a tertiary neonatal unit in Hong Kong.

Effectiveness and safety profile of introducing less invasive surfactant administration in management of respiratory distress syndrome: A retrospective cohort study in a tertiary neonatal unit in Hong Kong.

Journal: Pediatrics and neonatology

Published: August 23, 2023

HDAC7 promotes ovarian cancer malignancy via AKT/mTOR signalling pathway.

HDAC7 promotes ovarian cancer malignancy via AKT/mTOR signalling pathway.

Journal: Journal of cellular and molecular medicine

Published: April 29, 2023

Role of GPX4 inhibition-mediated ferroptosis in the chemoresistance of ovarian cancer to Taxol in vitro.

Role of GPX4 inhibition-mediated ferroptosis in the chemoresistance of ovarian cancer to Taxol in vitro.

Journal: Molecular biology reports

Published: April 29, 2023

Corrigendum to "Targeting G6PD reverses paclitaxel resistance in ovarian cancer by suppressing GSTP1" [Biochem. Pharmacol. 178 (2020), 114092].

Corrigendum to "Targeting G6PD reverses paclitaxel resistance in ovarian cancer by suppressing GSTP1" [Biochem. Pharmacol. 178 (2020), 114092].

Journal: Biochemical pharmacology

Published: September 11, 2021

mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer.

mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer.

Journal: Neoplasia (New York, N.Y.)

Published: March 25, 2021

Targeting G6PD reverses paclitaxel resistance in ovarian cancer by suppressing GSTP1.

Targeting G6PD reverses paclitaxel resistance in ovarian cancer by suppressing GSTP1.

Journal: Biochemical pharmacology

Published: March 23, 2020

HBXIP: a potential prognosis biomarker of colorectal cancer which promotes invasion and migration via epithelial-mesenchymal transition.

HBXIP: a potential prognosis biomarker of colorectal cancer which promotes invasion and migration via epithelial-mesenchymal transition.

Journal: Life sciences

Published: December 09, 2019

Comparison of direct sequencing and amplification refractory mutation system for detecting epidermal growth factor receptor mutation in non-small-cell lung cancer patients: a systematic review and meta-analysis.

Comparison of direct sequencing and amplification refractory mutation system for detecting epidermal growth factor receptor mutation in non-small-cell lung cancer patients: a systematic review and meta-analysis.

Journal: Oncotarget

Published: January 17, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026